Credentials in Regenerative Medicine

As more regenerative medicine standards become available, stakeholders in the community have expressed a need for more information on how their organizations can make use of these standards. The Standards Coordinating Body for Gene, Cell, and Regenerative Medicines and Cell-Based Drug Discovery (SCB) was closely involved in the development of the ISO 20391 cell counting series and the ISO 20399 ancillary materials standards, which support the vision of the 21st Century Cures Act of 2016. Additionally, the U.S. Food and Drug Administration recognizes the importance of standards in these sectors and has voiced interest in the increased development and adoption of regenerative medicine standards.

SCB – a non-profit whose mission is catalyzing standards development, harmonization, and adoption across the industry – is now working with Workcred to co-create the curriculum to implement the two standards series through assessment-based certificate programs. Once these programs are complete, the goal is to expand to other related standards and credentials.

Program Sponsor: